vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.

AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $32.0M, roughly 1.4× Silvercrest Asset Management Group Inc.). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -19.9%, a 19.6% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -0.0%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 2.7%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

ABCL vs SAMG — Head-to-Head

Bigger by revenue
ABCL
ABCL
1.4× larger
ABCL
$44.9M
$32.0M
SAMG
Growing faster (revenue YoY)
ABCL
ABCL
+788.4% gap
ABCL
788.4%
-0.0%
SAMG
Higher net margin
SAMG
SAMG
19.6% more per $
SAMG
-0.4%
-19.9%
ABCL
More free cash flow
SAMG
SAMG
$59.6M more FCF
SAMG
$15.0M
$-44.6M
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
2.7%
SAMG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
SAMG
SAMG
Revenue
$44.9M
$32.0M
Net Profit
$-8.9M
$-120.0K
Gross Margin
Operating Margin
-63.7%
-2.8%
Net Margin
-19.9%
-0.4%
Revenue YoY
788.4%
-0.0%
Net Profit YoY
73.9%
-107.4%
EPS (diluted)
$-0.03
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
SAMG
SAMG
Q4 25
$44.9M
$32.0M
Q3 25
$9.0M
$31.3M
Q2 25
$17.1M
$30.7M
Q1 25
$4.2M
$31.4M
Q4 24
$5.0M
$32.0M
Q3 24
$6.5M
$30.4M
Q2 24
$7.3M
$31.0M
Q1 24
$10.0M
$30.3M
Net Profit
ABCL
ABCL
SAMG
SAMG
Q4 25
$-8.9M
$-120.0K
Q3 25
$-57.1M
$618.0K
Q2 25
$-34.7M
$1.9M
Q1 25
$-45.6M
$2.5M
Q4 24
$1.6M
Q3 24
$-51.1M
$2.3M
Q2 24
$-36.9M
$2.7M
Q1 24
$-40.6M
$3.0M
Operating Margin
ABCL
ABCL
SAMG
SAMG
Q4 25
-63.7%
-2.8%
Q3 25
-851.8%
4.3%
Q2 25
-290.2%
13.2%
Q1 25
-1479.6%
15.4%
Q4 24
6.1%
Q3 24
-1439.4%
14.6%
Q2 24
-1276.2%
17.1%
Q1 24
-551.5%
19.5%
Net Margin
ABCL
ABCL
SAMG
SAMG
Q4 25
-19.9%
-0.4%
Q3 25
-637.8%
2.0%
Q2 25
-203.3%
6.3%
Q1 25
-1077.2%
7.9%
Q4 24
5.1%
Q3 24
-785.4%
7.4%
Q2 24
-504.3%
8.6%
Q1 24
-408.0%
9.9%
EPS (diluted)
ABCL
ABCL
SAMG
SAMG
Q4 25
$-0.03
$0.02
Q3 25
$-0.19
$0.07
Q2 25
$-0.12
$0.21
Q1 25
$-0.15
$0.26
Q4 24
$0.16
Q3 24
$-0.17
$0.24
Q2 24
$-0.13
$0.28
Q1 24
$-0.14
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
SAMG
SAMG
Cash + ST InvestmentsLiquidity on hand
$128.5M
$44.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
$50.3M
Total Assets
$1.4B
$166.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
SAMG
SAMG
Q4 25
$128.5M
$44.1M
Q3 25
$83.2M
$36.1M
Q2 25
$92.4M
$30.0M
Q1 25
$159.3M
$36.3M
Q4 24
$156.3M
$68.6M
Q3 24
$126.6M
$58.1M
Q2 24
$148.3M
$49.9M
Q1 24
$123.6M
$39.7M
Stockholders' Equity
ABCL
ABCL
SAMG
SAMG
Q4 25
$966.9M
$50.3M
Q3 25
$964.0M
$58.9M
Q2 25
$1.0B
$64.6M
Q1 25
$1.0B
$80.0M
Q4 24
$1.1B
$80.7M
Q3 24
$1.1B
$84.6M
Q2 24
$1.1B
$85.3M
Q1 24
$1.1B
$83.9M
Total Assets
ABCL
ABCL
SAMG
SAMG
Q4 25
$1.4B
$166.6M
Q3 25
$1.4B
$157.6M
Q2 25
$1.4B
$152.7M
Q1 25
$1.3B
$159.9M
Q4 24
$1.4B
$194.4M
Q3 24
$1.4B
$184.2M
Q2 24
$1.4B
$177.6M
Q1 24
$1.5B
$170.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
SAMG
SAMG
Operating Cash FlowLast quarter
$-34.7M
$18.6M
Free Cash FlowOCF − Capex
$-44.6M
$15.0M
FCF MarginFCF / Revenue
-99.4%
46.9%
Capex IntensityCapex / Revenue
21.9%
11.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$17.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
SAMG
SAMG
Q4 25
$-34.7M
$18.6M
Q3 25
$-52.6M
$14.6M
Q2 25
$-32.4M
$13.8M
Q1 25
$-11.6M
$-24.7M
Q4 24
$-108.6M
$21.6M
Q3 24
$-28.9M
$13.3M
Q2 24
$-30.0M
$16.0M
Q1 24
$-41.7M
$-24.1M
Free Cash Flow
ABCL
ABCL
SAMG
SAMG
Q4 25
$-44.6M
$15.0M
Q3 25
$-61.5M
$13.8M
Q2 25
$-45.8M
$13.4M
Q1 25
$-22.2M
$-25.1M
Q4 24
$-187.0M
$19.9M
Q3 24
$-47.4M
$12.9M
Q2 24
$-50.1M
$15.6M
Q1 24
$-65.8M
$-24.7M
FCF Margin
ABCL
ABCL
SAMG
SAMG
Q4 25
-99.4%
46.9%
Q3 25
-687.0%
44.1%
Q2 25
-267.9%
43.6%
Q1 25
-524.0%
-80.0%
Q4 24
-3702.8%
62.2%
Q3 24
-728.4%
42.4%
Q2 24
-683.8%
50.4%
Q1 24
-661.5%
-81.6%
Capex Intensity
ABCL
ABCL
SAMG
SAMG
Q4 25
21.9%
11.4%
Q3 25
99.7%
2.6%
Q2 25
78.2%
1.5%
Q1 25
251.1%
1.3%
Q4 24
1552.7%
5.3%
Q3 24
284.6%
1.2%
Q2 24
274.6%
1.1%
Q1 24
242.5%
2.0%
Cash Conversion
ABCL
ABCL
SAMG
SAMG
Q4 25
Q3 25
23.62×
Q2 25
7.22×
Q1 25
-10.01×
Q4 24
13.34×
Q3 24
5.90×
Q2 24
6.00×
Q1 24
-8.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

SAMG
SAMG

Investment Advisory Management And Administrative Service$30.7M96%
Tax And Family Office Services$1.2M4%

Related Comparisons